Sucralfate

Common brands: Carafate, Sucralfate Oral Suspension, Acid Reducer, Pantoprazole Sodium, Basic Care Omeprazole

Top reporter: Allergan, Inc.

Aluminum Complex [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Proton Pump Inhibitor [EPC]Corticosteroid [EPC]Benzodiazepine [EPC]
23,408
Total Reports
8,308
Serious Reports
2,285
Death Reports
30
Reported Reactions
Death Report Ratio: High (9.76%)

Patient Demographics

Male
7,157
Female
14,835

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Sucralfate.

# Reaction Reports % of Total
1 NAUSEA 2,311
7.2%
2 FATIGUE 1,767
5.5%
3 DIARRHOEA 1,735
5.4%
4 PAIN 1,500
4.7%
5 HEADACHE 1,408
4.4%
6 VOMITING 1,386
4.3%
7 DYSPNOEA 1,328
4.2%
8 DRUG INEFFECTIVE 1,317
4.1%
9 OFF LABEL USE 1,309
4.1%
10 DIZZINESS 1,059
3.3%
11 WEIGHT DECREASED 1,011
3.2%
12 ABDOMINAL PAIN 1,001
3.1%
13 CHRONIC KIDNEY DISEASE 985
3.1%
14 MALAISE 982
3.1%
15 PNEUMONIA 964
3.0%
16 ASTHENIA 953
3.0%
17 DEATH 902
2.8%
18 CONSTIPATION 870
2.7%
19 FALL 843
2.6%
20 ARTHRALGIA 828
2.6%
21 RENAL FAILURE 824
2.6%
22 ABDOMINAL PAIN UPPER 822
2.6%
23 PYREXIA 799
2.5%
24 ANAEMIA 761
2.4%
25 ACUTE KIDNEY INJURY 757
2.4%
26 ANXIETY 744
2.3%
27 GASTROOESOPHAGEAL REFLUX DISEASE 744
2.3%
28 BACK PAIN 699
2.2%
29 COUGH 687
2.2%
30 DECREASED APPETITE 654
2.0%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.